CHD vs CL

Key Takeaways

• Church & Dwight is in the midst of a significant portfolio transformation, having exited several underperforming businesses while acquiring high-growth brand TOUCHLAND, positioning for stronger organic growth ahead.
• Colgate-Palmolive commands dominant global market share in oral care — 41.3% in toothpaste and 32.4% in manual toothbrushes — and benefits from a diversified geographic footprint spanning six continents.
• CHD generated higher net margins (11.81% vs. 10.04%) but operates at roughly one-third the revenue scale of CL ($6.2 billion vs. $20.4 billion in 2025).
• CL offers a significantly higher dividend yield (approximately 2.3% vs. 1.3%) backed by 63 consecutive years of dividend increases, compared to CHD's 30-year streak.
• CHD's 2026 organic sales growth guidance of 3–4% outpaces CL's 1–4% range, though CL carries less volatility risk with a beta of 0.33 versus CHD's 0.47.
• Both stocks have attracted favorable analyst sentiment, with consensus ratings of Moderate Buy and price targets suggesting mid-single-digit upside from recent levels.

Introduction

Investors seeking exposure to the consumer staples sector often encounter two compelling but distinctly different names: CHD (Church & Dwight Co., Inc.) and CL (Colgate-Palmolive Company). Both are household-name manufacturers with decades of brand equity, global distribution networks, and track records of returning capital to shareholders. Yet their scale, growth strategies, and risk profiles diverge in meaningful ways. This comparison examines how these two consumer packaged goods (CPG) companies have performed in the current market environment, what has driven sentiment in recent weeks, and how an AI-powered analytical framework might assess their relative positioning for traders and long-term investors alike.

CHD Overview and Recent Performance

CHD (Church & Dwight) is a mid-cap consumer products company best known for its flagship ARM & HAMMER brand, alongside power brands including THERABREATH mouthwash, HERO acne products, TROJAN condoms, BATISTE dry shampoo, OXICLEAN stain removers, and the recently acquired TOUCHLAND hand sanitizer line. The company generated approximately $6.2 billion in net sales in 2025, with roughly 80% of revenue derived from the U.S. market.

Recent market activity reflects a company in transition. Over the past year, Church & Dwight has executed a strategic portfolio overhaul, exiting its vitamin business (VMS), FLAWLESS, SPINBRUSH, and WATERPIK showerhead lines. Excluding these exited businesses, U.S. consumption growth was a robust 3.5% — a stark contrast to the 0.9% reported figure. The acquisition of TOUCHLAND, the fastest-growing brand in the U.S. hand sanitizer category, has exceeded initial expectations and was elevated to the company's eighth power brand. In the fourth quarter of 2025, CHD delivered adjusted EPS (earnings per share) of $0.86, an 11.7% year-over-year increase, and full-year adjusted EPS reached $3.53, up 2.6%. Cash from operations surged to $1.215 billion, enabling $900 million in share repurchases. For 2026, management projects volume-led organic sales growth of 3–4% and adjusted EPS expansion of 5–8%, with momentum weighted toward the second half.

CL Overview and Recent Performance

CL (Colgate-Palmolive) is a consumer staples giant with approximately $20.4 billion in annual net sales and a market capitalization near $74 billion. The company holds dominant positions in global oral care — commanding 41.3% of the worldwide toothpaste market and 32.4% of the manual toothbrush category — and operates Hill's Pet Nutrition, which accounts for roughly 23% of total sales. Its geographic footprint spans North America, Latin America, Europe, Asia Pacific, and Africa/Eurasia, providing a level of diversification unmatched by smaller peers.

Colgate-Palmolive's recent performance has been shaped by external headwinds and internal repositioning. Full-year 2025 organic sales grew 1.4%, with base business EPS rising 3% to $3.69. The fourth quarter showed acceleration, with net sales up 5.8% and base business EPS of $0.95, a 4% increase. However, the company took a non-cash impairment charge of $794 million (after-tax) related to its skin health business, primarily the Filorga brand, citing weaker category growth and underperformance in China. Management has launched a three-year Strategic Growth and Productivity Program, with cumulative pre-tax charges projected at $200–$300 million, aimed at streamlining its organizational structure, optimizing the supply chain, and funding reinvestment in higher-growth areas. The company also completed its exit from private label pet food. Colgate-Palmolive returned $2.9 billion to shareholders in 2025 through dividends and buybacks, reinforcing its reputation as a dependable income compounder with 63 consecutive years of dividend growth.

Trending AI Robots

In an environment where two high-quality consumer staples stocks present different risk-reward trade-offs, technology is increasingly helping investors cut through the noise. Tickeron's Trending AI Robots page features a curated selection of AI-powered trading bots, handpicked from hundreds of available strategies based on their real-time suitability for current market conditions. These bots trade across thousands of tickers and employ diverse strategies — from swing trading and trend-following to mean-reversion and breakout models — across multiple timeframes. The bots featured in this section are those demonstrating the strongest alignment with prevailing market dynamics, with performance statistics that can include win rates, Sharpe ratios, and cumulative returns that help traders evaluate them at a glance. Each bot operates with its own distinct trading style and ticker universe, allowing users to find strategies matched to their risk tolerance. To explore which AI trading bots are currently leading the pack, visit the Trending AI Robots page.

Head-to-Head Comparison

While both CHD and CL operate in the consumer staples space, their investment profiles diverge along several critical dimensions. Scale and diversification heavily favor Colgate-Palmolive, whose $20.4 billion revenue base and presence across six continents provide insulation against regional economic softness. Church & Dwight, at $6.2 billion in sales and with 80% U.S. exposure, carries more concentration risk but also benefits from a nimbler, more focused brand portfolio where successful innovations can move the needle faster.

Profitability metrics tilt in CHD's direction on margin quality — its 11.81% net margin outpaces CL's 10.04%, and CHD's adjusted gross margin of 45.2% demonstrates strong pricing power. However, CL's return on assets (ROA) of 17.89% nearly doubles CHD's 9.62%, reflecting more efficient asset utilization at scale.

Growth trajectory is another area of contrast. CHD's 2026 organic sales outlook of 3–4% reflects the benefit of portfolio cleanup and acquisition momentum from TOUCHLAND. CL's 1–4% organic sales growth guidance is wider and more conservative, weighed down by the skin health restructuring and subdued category growth globally. On the other hand, CL's 2030 strategy and productivity program could unlock significant operating leverage over the medium term.

Income appeal strongly favors Colgate-Palmolive, with a 2.3% dividend yield versus CHD's 1.3%, and a 63-year dividend growth streak that ranks among the longest in corporate America. CHD's 30-year streak is impressive in its own right, but the payout ratio is more conservative at roughly 40%, leaving ample room for increases. Risk considerations also differ: CL's beta of 0.33 indicates lower market sensitivity than CHD's 0.47, though both are well below the broader market average, consistent with their defensive sector classification.

Tickeron AI Verdict

Based on observable trend consistency, relative momentum, and catalyst clarity, Tickeron's AI analytical framework would likely express a modest preference for CHD (Church & Dwight) in the current environment. The reasoning is probabilistic rather than definitive: CHD has completed the heavy lifting of portfolio restructuring, and the exit from underperforming businesses combined with the early success of TOUCHLAND creates a cleaner growth narrative heading into 2026. The company's 3–4% organic sales growth guidance — which is volume-led rather than price-dependent — suggests healthier underlying demand. Meanwhile, CL (Colgate-Palmolive) remains a higher-quality defensive compounder with unmatched global reach, but its near-term path is complicated by the skin health impairment, the ramp-up of its productivity program, and sluggish category growth in key markets. For traders prioritizing near-to-medium-term momentum and catalyst-driven upside, CHD's cleaner setup may hold greater appeal. For those prioritizing stability, income, and global diversification, CL's profile remains difficult to match. The AI would likely note that both stocks warrant attention, but for different investor objectives.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.